Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK Markets closed
FTSE 100
7,952.62
+20.64
(+0.26%)
FTSE 250
19,884.73
+74.07
(+0.37%)
AIM
743.26
+1.15
(+0.15%)
GBP/EUR
1.1692
-0.0002
(-0.01%)
GBP/USD
1.2625
+0.0002
(+0.0189%)
BTC-GBP
55,491.69
-148.45
(-0.27%)
Celldex Therapeutics, Inc. (CLDX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
41.97
+0.18
(+0.43%)
At close: 04:00PM EDT
41.80
-0.17
(-0.41%)
After hours:
07:05PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,883
6,883
2,357
4,651
7,418
Operating expenses
Research development
118,011
118,011
82,258
53,311
42,534
Selling general and administrative
30,914
30,914
27,195
20,488
14,456
Total operating expenses
148,925
148,925
109,453
73,799
56,990
Operating income or loss
-142,042
-142,042
-107,096
-69,148
-49,572
Total other income/expenses net
613
613
-5,229
-1,590
-11,375
Income before tax
-141,429
-141,429
-112,325
-70,738
-60,947
Income tax expense
0
0
0
-227
-1,167
Income from continuing operations
-141,429
-141,429
-112,325
-70,511
-59,780
Net income
-141,429
-141,429
-112,325
-70,511
-59,780
Net income available to common shareholders
-141,429
-141,429
-112,325
-70,511
-59,780
Basic EPS
-1.64
-2.92
-2.40
-1.64
-2.02
Diluted EPS
-1.64
-2.92
-2.40
-1.64
-2.02
Basic average shares
42,870
48,449
46,888
42,870
29,640
Diluted average shares
42,870
48,449
46,888
42,870
29,640
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy choices
About our ads
© 2024 Yahoo. All rights reserved.